John C. K. Milligan IV
Net Worth
Last updated:
What is John C. K. Milligan IV net worth?
The estimated net worth of Mr. John C. K. Milligan IV is at least $10,750,602 as of 11 May 2021. He owns shares worth $1,945,500 as insider, has earned $46,022 from insider trading and has received compensation worth at least $8,759,080 in TherapeuticsMD, Inc..
What is the salary of John C. K. Milligan IV?
Mr. John C. K. Milligan IV salary is $796,280 per year as Chief Executive Officer of VitaCare Prescription Services in TherapeuticsMD, Inc..
How old is John C. K. Milligan IV?
Mr. John C. K. Milligan IV is 63 years old, born in 1962.
What stocks does John C. K. Milligan IV currently own?
As insider, Mr. John C. K. Milligan IV owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | Chief Executive Officer of VitaCare Prescription Services | 1,752,703 | $1.11 | $1,945,500 |
What does TherapeuticsMD, Inc. do?
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
John C. K. Milligan IV insider trading
TherapeuticsMD, Inc.
Mr. John C. K. Milligan IV has made 24 insider trades between 2014-2021, according to the Form 4 filled with the SEC. Most recently he sold 44,252 units of TXMD stock worth $46,022 on 11 May 2021.
The largest trade he's ever made was exercising 353,412 units of TXMD stock on 26 Mar 2014. As of 11 May 2021 he still owns at least 1,752,703 units of TXMD stock.
TherapeuticsMD key executives
TherapeuticsMD, Inc. executives and other stock owners filed with the SEC:
- Dr. Brian A. Bernick (57) Co-Founder & Chief Scientific Officer
- Mr. John C. K. Milligan IV (63) Chief Executive Officer of VitaCare Prescription Services
- Mr. Robert G. Finizio (54) Co-Founder & Vice Chair